ELVN

Enliven Therapeutics (ELVN) is the lead sponsor of 4 active clinical trials listed on ClinicalTrials.gov^[2], including 4 Phase 1^[1].

ELVN has 2 Form 4 insider filings recorded at the SEC in the past 30 days^[3].